Prostate‐specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy
2023; Wiley; Volume: 133; Issue: S4 Linguagem: Inglês
10.1111/bju.16207
ISSN1464-410X
AutoresBart Geboers, Dennie Meijer, William Counter, Alexandar Blazevski, James Thompson, Paul Doan, William Gondoputro, Athos Katelaris, Anne‐Maree Haynes, Warick Delprado, Gordon O’Neill, Carlo Yuen, André N. Vis, Pim J van Leeuwen, Bao Ho, Victor Liu, Jonathan Lee, Maarten L. Donswijk, Daniela E. Oprea‐Lager, Matthijs J. Scheltema, Louise Emmett, Phillip D. Stricker,
Tópico(s)Radiomics and Machine Learning in Medical Imaging
ResumoTo evaluate the additional value of prostate-specific membrane antigen positron emission tomography (PSMA-PET) to conventional diagnostic tools to select patients for hemi-ablative focal therapy (FT).
Referência(s)